Merck Publishes 2013 Global Corporate Responsibility Report
August 05 2014 - 1:00PM
Business Wire
Merck (NYSE:MRK), known as MSD outside of the United States and
Canada, today issued its 2013 global corporate responsibility
report. The report, available at www.merckresponsibility.com,
focuses on the company’s corporate responsibility activities,
progress and performance during 2013 in four priority areas where
Merck is positioned to have a positive impact: Access to Health,
Environmental Sustainability, Employees and Ethics and
Transparency.
Highlights from the 2013 report include:
- Reached more than 340 million people
through our major programs and partnerships to help address
barriers to access
- Continued to work with partners to help
ensure that infants and girls in the poorest countries have access
to our vaccines
- Through our ground-breaking partnership
to treat river blindness, Colombia became the first country to
eliminate the disease
- Working in close collaboration with
more than 75 implementing partners, Merck for Mothers initiated
more than 50 projects in 30 countries
- Implemented a new streamlined
environmental strategy that focuses on the issues that are most
important to our business and our stakeholders
- Narrowed our environmental
sustainability goals to the critical few that align with our
business and focus on key global environmental challenges
- Leveraged the scientific and business
skills of our employees through the Richard T. Clark Fellowship for
World Health to help address the health needs of underserved
populations
- Recognized for the 11th consecutive
year as a Top 50 Company for Diversity by DiversityInc
- Ranked No.1 in the CPA-Zicklin Index of
Corporate Political Disclosure and Accountability for three
consecutive years
Merck continues to use several external guidelines and
measurement frameworks to inform the scope of its reporting,
including the Global Reporting Initiative (GRI G4) Guidelines, the
Millennium Development Goals, the Access to Medicine Index and the
United Nations Global Compact.
In addition to the comprehensive report at
www.merckresponsibility.com, Merck has published an executive
summary highlighting various programs and partnerships that
exemplify the company’s corporate responsibility commitments. The
executive summary is available at www.merckresponsibility.com and
www.merckcr.com.
Future information will be provided through a Twitter
conversation at #BeWell.
About Merck
Today's Merck is a global healthcare leader working to help the
world be well. Merck is known as MSD outside the United States and
Canada. Through our prescription medicines, vaccines, biologic
therapies, and consumer care and animal health products, we work
with customers and operate in more than 140 countries to deliver
innovative health solutions. We also demonstrate our commitment to
increasing access to healthcare through far-reaching policies,
programs and partnerships. For more information, visit
www.merck.com and connect with us on Twitter, Facebook and
YouTube.
Merck Forward-Looking Statement
This news release includes “forward-looking statements” within
the meaning of the safe harbor provisions of the United States
Private Securities Litigation Reform Act of 1995. These statements
are based upon the current beliefs and expectations of Merck’s
management and are subject to significant risks and uncertainties.
If underlying assumptions prove inaccurate or risks or
uncertainties materialize, actual results may differ materially
from those set forth in the forward-looking statements.
Risks and uncertainties include but are not limited to, general
industry conditions and competition; general economic factors,
including interest rate and currency exchange rate fluctuations;
the impact of pharmaceutical industry regulation and health care
legislation in the United States and internationally; global trends
toward health care cost containment; technological advances, new
products and patents attained by competitors; challenges inherent
in new product development, including obtaining regulatory
approval; Merck’s ability to accurately predict future market
conditions; manufacturing difficulties or delays; financial
instability of international economies and sovereign risk;
dependence on the effectiveness of Merck’s patents and other
protections for innovative products; and the exposure to
litigation, including patent litigation, and/or regulatory
actions.
Merck undertakes no obligation to publicly update any
forward-looking statement, whether as a result of new information,
future events or otherwise. Additional factors that could cause
results to differ materially from those described in the
forward-looking statements can be found in Merck’s 2013 Annual
Report on Form 10-K and the company’s other filings with the
Securities and Exchange Commission (SEC) available at the SEC’s
Internet site (www.sec.gov).
For MerckMedia:Lainie Keller, 908-423-4187orInvestors:Justin
Holko, 908-423-5088
Merck (NYSE:MRK)
Historical Stock Chart
From Mar 2024 to Apr 2024
Merck (NYSE:MRK)
Historical Stock Chart
From Apr 2023 to Apr 2024